OMRF identifies potential ovarian cancer therapy
A scientist at the Oklahoma Medical Research Foundation has discovered a targeted therapy that could improve treatment and long-term outcomes for ovarian cancer.
The findings from OMRF researcher Magdalena Bieniasz, Ph.D., could pave the way for better personalized medicine options for women who have the deadliest form of the disease. Known as high-grade serous ovarian carcinoma, it accounts for…